Bioventus Launches DUROLANE in Malaysia

Bioventus launched DUROLANE® single-injection joint fluid osteoarthritis (OA) therapy in Malaysia, through exclusive distribution partner Athrotech.

The company cited estimates of 20% of the adult Malaysian population has OA, noting that knee OA is the most common form. Further, the market exhibits a favorable mix...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us